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Yoshiyuki Yamashita*, Kazuhiro Kurisu, Satoshi Kimura and Yasutaka UenoAbstract
Although liposarcoma often metastasizes to various organs, cardiac metastasis, including to the pericardium, is rare. We
present a case of a third recurrence of pericardial metastasis from the thigh, which required surgical resection because
of cardiac failure. Surgery was effective for improving cardiac function and reintroducing chemotherapy. This is the first
reported case of metastatic pericardial liposarcoma, which was successfully resected three times. We believe that
aggressive surgical treatment, when it can resolve cardiac impairment, potentially leads to a more favorable prognosis.
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Liposarcoma is one of the most common soft tissue
sarcomas in adults and often develops in the retroperi-
toneum and lower limbs. This tumor usually metasta-
sizes to different organs, but metastasis to the heart,
including to the pericardium, is rare. We report a pa-
tient with repeated cardiac metastases that required
surgical resection.
Case presentation
A 66-year-old woman was referred to our hospital be-
cause of recurrence of pericardial metastatic liposarcoma
with progressive dyspnea. The patient had undergone
surgical resection of a primary liposarcoma in the left
thigh 19 years previously and resection of a locally re-
current tumor 13 years previously. She developed car-
diac and pericardial metastasis 10 years later. Resection
of a cardiac metastasis originating from the right ven-
tricle was performed via median sternotomy 3 years pre-
viously, and a second resection followed by radiotherapy
for recurrence of the pericardium metastasis adjacent to
the diaphragm 2 years previously. Each of these meta-
static tumors was large enough to result in cardiac* Correspondence: yossan43433@yahoo.co.jp
Department of Cardiovascular Surgery, Shimonoseki City Hospital, 1-13-1
Koyo-cho, Shimonoseki, Yamaguchi 750-8520, Japan
© 2015 Yamashita et al. Open Access This arti
International License (http://creativecommons.o
reproduction in any medium, provided you giv
the Creative Commons license, and indicate iffailure. The pathological diagnosis of the resected pri-
mary and metastatic tumors was myxoid liposarcoma.
The third recurrence of metastatic pericardial liposarcoma
was detected 1 year previously and was followed by metas-
tasis to the posterior mediastinum, liver, retroperitoneum,
and peritoneum. Chemotherapy including gemcitabine,
docetaxel, pazopanib, and epirubicin was administered for
1 year. Chemotherapy was effective for all of the metasta-
ses except those in the pericardium and posterior medias-
tinum. As the pericardial metastasis enlarged, the patient
developed dyspnea over a period of several months. Her
symptoms were speculated to be due to diastolic impair-
ment by the large tumor. Reintroduction of chemotherapy
was difficult because of cardiac failure. Therefore, she was
referred to our hospital for surgical treatment of the peri-
cardial metastasis.
On admission, the patient had moderate dyspnea.
Signs of cardiac failure, including engorgement of the
jugular vein and edema of the lower extremities, were
observed. Laboratory data showed an elevated brain
natriuretic peptide level of 524 pg/ml. Chest X-ray
showed a large mass lateral to the left ventricle extend-
ing to the left chest wall. Echocardiography showed a
mass lateral to the main pulmonary artery in the peri-
cardium. The left ventricular ejection fraction was pre-
served (60.9 %), but the inferior vena cava was dilated.cle is distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and








Fig. 1 Preoperative computed-tomography images. Computed tomography of a horizontal dislocation and b coronal dislocation showing a large
mass in the pericardium anterolateral to the main pulmonary artery (A). Horizontal dislocation also showed a mass in the posterior mediastinum
posterior to the bronchi (B). PA pulmonary artery
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density mass in the pericardium. This mass extended
laterally to the ascending aorta and aortic arch, antero-
laterally to the main pulmonary artery, and anteriorly to
the left pulmonary artery (Fig. 1). The mass was specu-
lated to be partially involved in the pulmonary artery.
Masses were also identified in the posterior mediasti-
num, liver, retroperitoneum, and peritoneum. At the
time of cardiac catheterization, the right atrial pressure
and pulmonary capillary wedge pressure were elevated
(11 and 17 mmHg, respectively), and simultaneous
measurement of the right and left ventricular pressure
demonstrated elevated and nearly equal end-diastolic
pressure (16 and 18 mmHg, respectively). The patient’s
hemodynamic data corresponded to diastolic impairment.
Accordingly, resection of the pericardial tumor was rec-
ommended. We performed a median re-sternotomy
along the previous skin incision. Moderate adhesionT
Ao
Fig. 2 Intraoperative picture. A large tumor can be seen anterolateral to thwas present between the heart and chest wall, and we
safely exposed the right ventricle, right atrium, and as-
cending aorta (Fig. 2). A mucinous mass measuring ap-
proximately 30 × 20 × 10 mm, which was not recognized
before the operation, was observed between the dia-
phragm and right ventricle and was resected (Fig. 3).
The mass and involved pericardium were easily de-
tached from the main and left pulmonary arteries and
ascending aorta, and we did not need to use cardiopul-
monary bypass. The mass comprised three parts, all of
which were mucinous and measured approximately
100 × 50 × 20 mm each. We performed en bloc resection
of two of the three masses (Fig. 3), but the other was
vulnerable and disintegrated. Therefore, we removed
them as much as possible. The total weight of the
masses was 610 g. The pathological diagnosis of the
large masses was myxoid liposarcoma, and that of the
smaller mass was myxoid and round-cell liposarcomaRV
e main pulmonary artery (T). Ao ascending aorta, RV right ventricle
Fig. 3 Picture of the en bloc resected tumors. Two large masses were
anterolateral to the main pulmonary artery, and one small mass was
adjacent to the right ventricle. All of them were soft and mucinous
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course, and her symptoms markedly improved. Cardiac
catheterization showed a decreased pulmonary capillary
wedge pressure of 10 mmHg. Two months later, she
underwent resection of the posterior mediastinal metas-
tasis, which had become larger in spite of the chemo-
therapy, to reduce the tumor volume. This was
performed via video-assisted left posterolateral thora-
cotomy. Chemotherapy was then reintroduced, and the
patient was in good condition 3 months after the car-
diac surgery. Computed tomography 3 months after the
cardiac surgery showed no evidence of recurrence in the
pericardium (Fig. 5).Discussion
Liposarcoma is the second most common malignancy
of soft tissues. The most common primary sites of lipo-
sarcoma are the retroperitoneum and lower limbs. Al-
though liposarcoma often metastasizes to different
organs, cardiac metastasis, including to the pericar-
dium, is rare. Thirty-five cases of metastatic cardiac
liposarcoma have been reported in the literature [1–6],
with only nine cases of pericardial metastases [2–4].Fig. 4 Histological findings of the resected tumors. Histological findings sh
hematoxylin-eosin, ×100) and a part of the tumor adjacent to the right venAccording to the WHO classification, liposarcoma is di-
vided into the following categories: well-differentiated,
differentiated, myxoid, round-cell, pleomorphic, mixed-
type liposarcoma, and liposarcoma, not otherwise speci-
fied. Myxoid and well-differentiated liposarcomas have
more favorable 5-year survival rates than round-cell and
pleomorphic types. The first choice of therapy for pri-
mary liposarcoma is surgical resection. However, local
recurrence or distant metastasis often occurs even many
years after surgery. Radiotherapy combined with surgery
may be associated with less recurrence [7]. Chemother-
apy is an option in the case of metastatic or unresect-
able disease [8], but it is still an empirical decision
owing to the lack of evidence. Pericardial metastasis of
liposarcoma often manifests as diastolic cardiac impair-
ment. Surgical resection of cardiac or pericardial metas-
tasis is usually recommended as a potentially radical
treatment for solitary lesions without any other metas-
tasis and is occasionally adopted as a palliative proced-
ure in patients with other metastases. In our case, the
patient had symptoms of cardiac failure because of im-
paired diastolic filling caused by the pericardial metasta-
sis. She could not undergo chemotherapy because of
cardiac failure. Resection of the tumor was expected to
relieve the diastolic impairment and provide a chance of
reintroduction of chemotherapy, which could have po-
tentially prolonged her prognosis. Therefore, we de-
cided to perform a third intervention, and the strategy
was effective. This is the first reported case of meta-
static pericardial liposarcoma, which was successfully
resected three times. The prognosis of patients with car-
diac metastatic liposarcoma is usually poor. Aoyama
et al. [9] reported 15 cases of metastatic cardiac liposar-
coma; six patients died within 6 months, and the longest
follow-up was 15 months. However, the follow-up
period of our patient from the first resection of the peri-
cardial metastasis was 51 months. To the best of our
knowledge, this is the longest reported follow-up of
pericardial metastasis of liposarcoma. Aggressive surgi-
cal treatment with the intention of resolving the cardiacowing that almost all of the tumors were myxoid liposarcomas (a,
tricle was round-cell liposarcoma (b, hematoxylin-eosin, ×200)
Fig. 5 Postoperative computed-tomography images. Computed
tomography showed that the pericardial tumor was almost totally
resected and there was no evidence of recurrence
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even a prolonged prognosis.
Conclusions
We successfully resected a pericardial metastatic liposar-
coma, resulting in symptom improvement and reintroduc-
tion of chemotherapy. Aggressive surgical therapy may
provide a symptom-free interval and prolonged prognosis.
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